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Background: Diffuse traumatic axonal injury (TAI), a common consequence of traumatic brain injury, is associated
with high morbidity and mortality. Inflammatory processes may play an important role in the pathophysiology of
TAI. In the central fluid percussion injury (cFPI) TAI model in mice, the neuroinflammatory and astroglial response
and behavioral changes are unknown.
Methods: Twenty cFPI-injured and nine sham-injured mice were used, and the neuroinflammatory and astroglial
response was evaluated by immunohistochemistry at 1, 3 and 7 days post-injury. The multivariate concentric square
field test (MCSF) was used to compare complex behavioral changes in mice subjected to cFPI (n = 16) or sham
injury (n = 10). Data was analyzed using non-parametric statistics and principal component analysis (MCSF data).
Results: At all post-injury time points, β-amyloid precursor protein (β-APP) immunoreactivity revealed widespread
bilateral axonal injury and IgG immunostaining showed increased blood–brain barrier permeability. Using vimentin
and glial fibrillary acidic protein (GFAP) immunohistochemistry, glial cell reactivity was observed in cortical regions
and important white matter tracts peaking at three days post-injury. Only vimentin was increased post-injury in the
internal capsule and only GFAP in the thalamus. Compared to sham-injured controls, an increased number of
activated microglia (MAC-2), infiltrating neutrophils (GR-1) and T-cells (CD3) appearing one day after TAI (P<0.05 for
all cell types) was observed in subcortical white matter. In the MCSF, the behavioral patterns including general
activity and exploratory behavior differed between cFPI mice and sham-injured controls.
Conclusions: Traumatic axonal injury TAI resulted in marked bilateral astroglial and neuroinflammatory responses
and complex behavioral changes. The cFPI model in mice appears suitable for the study of injury mechanisms,
including neuroinflammation, and the development of treatments targeting TAI.
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Diffuse axonal injury (DAI) results from rapid acceler-
ation/deceleration or rotation of the brain, subjecting
axons to mechanical shearing and stretch forces. DAI is
frequently observed following traffic accidents, sports in-
juries and falls, and across the entire spectrum of trau-
matic brain injury (TBI) severity [1-4]. The morbidity
and mortality associated with TBI are closely linked to
the extent of axonal injury in subcortical, central and
brainstem white matter tracts. A major consequence of
DAI is unconsciousness and persistent vegetative state
that can be observed up to many years following human
TBI [2,5-11]. Axonal damage has also recently been rec-
ognized as a key predictor of outcome in other human
central nervous system (CNS) diseases including spinal
cord injury, metabolic encephalopathy and multiple
sclerosis [12]. Unfortunately, spontaneous axonal regen-
eration is strictly limited following axonal injury in the
CNS. Although several pharmacological compounds such
as antibodies targeting Nogo-A and/or its receptors have
shown promising preclinical efficacy in axonal injury
models, there are currently no treatment options with
proven clinical efficacy available for DAI patients [13-15].
On the cellular level, axonal injuries can be morpho-
logically characterized by antibodies targeting the amyloid
precursor protein (β-APP) identifying impaired axonal
transport [16-21]. Accumulation of β-APP is a hallmark
finding of DAI, occurring either as periodic localized
swellings, axonal varicosities or as a single large axonal
swelling, the classical axonal bulb [22]. In order to under-
stand the complex pathophysiology of DAI and to develop
novel treatments, clinically-relevant animal models of
traumatic axonal injury (TAI, the experimental counter-
part of DAI) are needed. The central fluid percussion in-
jury (cFPI) [23] and the impact acceleration injury model
[24] are both useful models for studying TAI in the rat
with features mimicking human DAI. Mouse models of
TBI have several advantages in the study of cellular and
molecular injury responses and recently, the cFPI model
of TAI was adopted for the mouse [5]. The neuro-
inflammatory response to TAI was previously studied
using cFPI in the rat [25] and closed head injury in mice
[26] where long-term microglial activation was observed.
To our knowledge, glial cell reactivity, inflammatory re-
sponses and behavioral outcome have not previously been
studied in the novel mouse cFPI TAI model. In the
present study, mice subjected to a moderate cFPI were
followed for up to one week post-injury where glial cell re-
activity and the inflammatory responses were evaluated
using immunohistochemistry.
Since behavioral disturbance is a common clinical prob-
lem, behavioral evaluation was used and we hypothesized
that TAI produces unique behavioral changes. Thus, the
functional outcome was analyzed at 2 to 9 days post-injury using the multivariate concentric square field
(MCSF) test comparing complex behavioral patterns of
mice subjected to cFPI to those of sham-injured controls
[27,28]. We show that the cFPI model causes a dynamic
and widespread, bilateral astroglial and neuroinflam-
matory response in addition to axonal injury in important
white matter tracts. The astroglial response was more
widespread than the axonal injury and neuroinflammatory
response. Compared to sham-injured controls, mice
subjected to cFPI had different behavioral patterns. The
cFPI model also appeared to induce unique behavioral
deficits, suggested by comparing previously published be-
havioral MCSF data obtained from mice subjected to a
widely used focal contusion TBI model [28]. Thus, the
cFPI model in mice appears highly suitable for the study
of TAI-related injury mechanisms and our results lead us
to hypothesizethat glial reactivity and neuroinflammation
play important roles in the pathophysiology of axonal in-
jury following TBI.
Methods
Animal care and housing
Male adult C57BL/6 mice (Taconic, Denmark) housed in
groups of six per cage with food and water ad libitum on
a 12-h light/dark cycle with lights on at 7.00 AM were
used in the study. All animals remained in the animal care
facility for a minimum of seven days prior to the experi-
ments. Twenty-nine mice (weight 21 to 28 g) were used
for the immunohistochemical study and 30 mice (weight
22 to 29 g) for the functional outcome evaluation. Behav-
ioral testing was performed during the light period of the
cycle. To reduce stress, animals were handled for one
week prior to the behavioral testing. Handling procedures
included daily transfer from the home cage and placement
of the mouse on the arm of the scientist for 1 to 2 min
after which it was returned to its home cage. The same
scientist (S.E-L) conducted the surgical procedures and
functional outcome studies. All experiments were ap-
proved by the Uppsala County Animal Ethics board, and
followed the rules and regulations of the Swedish Animal
Welfare Agency. All analyses were performed by investiga-
tors blinded to the injury status and survival time point of
each animal.
Central fluid percussion injury (cFPI)
For the immunohistochemical evaluation, mice were ran-
domly subjected to either cFPI (n = 20) or sham injury
(n = 9). Three animals died immediately following the
injury due to prolonged apnea and two animals were
excluded from the study due to a dural tear. In total, the
study included five brain-injured and three sham-
injured mice per time point, allowed to survive 1, 3 or 7
days post-injury. For the functional outcome evaluation,
20 animals were subjected to cFPI. Four animals died
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The exclusion criteria for apnea duration were set to a
maximum of 60 seconds [29,30]. Sham-injured animals
(n = 10) were subjected to anesthesia and surgical prep-
aration including craniotomy but did not receive the
pressure pulse.
The cFPI surgical procedure was modified from those
previously described by Dixon et al. [27] in rats and by
Greer et al. [5] in mice. Anesthesia was induced in a
chamber with 4% isoflurane in air. The mice were moved
to a stereotaxic frame and a mixture of isoflurane (1.2 to
1.4%) and N2O/O2 (70/30%) was delivered through a nose
cone to maintain general anesthesia under spontaneous
breathing. Body temperature was maintained at 37°C by a
heating pad coupled to a rectal probe (CMA 150, CMA
Microdialysis AB, Solna, Sweden) aided by an overhead-
heating lamp. After shaving and cleansing the skin with
ethanol, bupivacaine 2.5 mg/mL (MarcaineW, AstraZeneca,
Sweden) was subcutaneously applied and the scalp was
opened by a midline incision. Artificial tear lubricant
(Viscotears, Novartis, Inc., Basel, Switzerland) was used for
corneal protection during anesthesia.
A 3.0 mm diameter craniotomy was made in the mid-
line between the bregma and lambda sutures, leaving the
underlying dura intact. Hemorrhages, if present, were
controlled by gentle pressure on the bone edge with a
Q-tip. The bone flap was placed subcutaneously during
the preparation for cFPI. A plastic cap was secured over
the craniotomy using dental cement (HeraeusKulzer
GmbH, Hanau, Germany), and the integrity of the seal
between the cap and the skull was confirmed by adding
normal saline into the cap (Figure 1 A,B). Injury was pro-
duced by attaching the saline-filled hub to the Luer-Lok
fitting on the fluid percussion device (VCU Biomedical
Engineering Facility, Richmond, VA, USA) and releasing aBA
Figure 1 Central fluid percussion injury (cFPI) procedure. (A) To prepa
between the bregma and lambda sutures, leaving the underlying dura inta
over the craniotomy; (C) Overview of the bregma levels where the differenpendulum striking the end of a saline-filled reservoir
transmitting a pressure wave into the closed cranial cavity.
The pressure pulse measured by the transducer was
displayed on an oscilloscope and the peak pressure was
recorded in atmospheres (atm). Immediately after the
injury, the animal was inspected for apnea and seizures
defined as fore- and/or hind-limb twitching. Following
resumption of spontaneous breathing, the mouse was
re-anesthetized with isoflurane and the cement and cap
were removed, the bone flap was dried and replaced
over the craniotomy, and the skin was closed with
sutures. Animals were moved to a cage placed under a
warming lamp until recovered from anesthesia and fully
ambulatory. As a measure of animal health, the weight
of the animal was monitored daily for a minimum of
three days following injury, or until they showed weight
gain. Weight-loss more than 20% was an exclusion
criterion, mandated by the animal ethics committee.Morphological methods
Immunostaining
At time for sacrifice, mice were given an overdose of
isoflurane and were transcardially perfused with 4%
formaldehyde. The brains were cryoprotected in 30% suc-
rose and snap frozen in cold isopentane, and thereaf-
ter cryosectioned (HM500, Microm GmbH, Walldorf,
Germany). Fourteen μm thick coronal sections from
bregma levels 0, -1.5, -2.5 and −3.5 mm [31] were analyzed
(Figure 1C). On each glass, three consecutive sections were
mounted. Additionally, the brain stems were cut sagitally.
For general morphology, sections from level −1.5 mm
bregma were fixed in acetone, rehydrated in alcohol (ab-
solute ethanol to 80% ethanol) and washed in tap water.


















re for cFPI, a 3.0 mm diameter craniotomy was made in the midline
ct; (B) Using dental cement, a cap filled with normal saline was sealed
t immunohistochemical analyses were prepared.
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for a few seconds and dehydration in alcohol (80% to ab-
solute ethanol and xylene), and finally mounted.
Sections prepared for immunohistochemistry were
fixed in cold acetone, washed in phosphate buffered
saline (PBS) and treated in pre-heated citrate buffer for
5 min. They were then washed in PBS and incubated in
peroxidase blocking solution (DakoCytomation A/S,
Glostrup, Denmark) for 20 min, washed and blocked
with 10% serum (horse or goat serum depending on the
primary antibody) in PBS with 0.3% triton-X. The pri-
mary antibodies were used over night at 4°C (Table 1).
Sections stained for blood–brain barrier (BBB) leakage
were not incubated with a primary antibody; instead,
only a biotinylated anti-mouse IgG secondary antibody
was used at 1:100 for one hour in room temperature
(Vector Laboratories, Burlingame, CA, USA). Sections
were thereafter washed with PBS and incubated for 60
min with a secondary biotinylated antibody (Table 1).
Following washing with PBS, sections were incubated for
30 min with avidin-biotin-peroxidase complex (Vector La-
boratories) at a dilution of 1:200. Staining was developed
using 3’,3’-diamionbenzidine (DAB, Vector Laboratories)
as chromogen and was counterstained with hematoxylin.
To intensify the reaction product of β-APP and CD3, the
nickel enhancement procedure was applied. Negative con-
trols included omission of the primary antibody. As a
positive control for CD3 staining, mouse spleen was used.
Staining for terminal deoxynucleotidyltransferasedUTP
nick end labeling (TUNEL) included incubation with cit-
rate buffer for 60 min in 90°C, incubation with 5% normal
goat serum and 0.3% Triton-X in PBS and incubation with
TUNEL mix (Roche Diagnostics GmbH, Mannheim,
Germany) for 60 min at room temperature. Sections were
then washed in PBS and mounted using Vectashield with
DAPI (Vector Laboratories).Table 1 Overview of the primary and secondary antibodies
Antibody Host animal/concentration
β-APP Rabbit, 1:200 Amyloid
Vimentin Goat, 1:200 A
GFAP Rabbit, 1:500 A
MAC-2 Rat, 1:200 M
GR-1 Rat, 1:200 N
CD3 Hamster, 1:100
Biotinylated anti-mouse IgG Mouse, 1:100 Blood bra
Biotinylated anti-rabbit IgG Rabbit, 1:200 Secon
Biotinylated anti-goat IgG Goat, 1:200 Secon
Biotinylated anti-rat IgG Rat, 1:200 Secon
Biotinylated anti-hamster IgG Hamster, 1:200 SeconMicroscope analysis and cell quantification
Sections were analyzed in the microscope (Zeiss
Axiovision, Zeiss Gmbh, Göttingen, Germany) and
immunohistochemical images were captured for cell
counting of Gr-1 and Mac-2. Using Axiovision image
analysis software (Zeiss Axiovision), images for quanti-
fication of immune cells were analyzed from bregma
levels 0; -1.5; -2.5 and −3.5 mm ([31], two to three sec-
tions per animal) in the following white matter tracts;
corpus callosum, external capsule and fimbria of hippo-
campus. CD3-positive cells were manually and exhaust-
ively counted at 20× magnification directly in the
microscope at the level of bregma −1.5 and −2.5 mm
(one section per bregma level). A grid of 700×500 μm
was placed in the region of interest in all evaluated
white matter tracts (the corpus callosum, external cap-
sule and the fimbriae; Figure 2C). The total number of
cells per animal was used and the mean number of
cells per group is presented. For hematoxylin and eosin
staining and BBB staining, bregma level −1.5 mm
(three sections per animal) was analyzed for all ani-
mals. β-APP, vimentin, GFAP and TUNEL staining was
analyzed at all levels (bregma level 0, -1.5, -2.5 and
−3.5, two to three sections per level). To test the hy-
pothesis that the cFPI model in mice also produces
brain stem axonal injury, three sagittal sections from
the brain stem (Figure 1C) of each animal were
descriptively evaluated for β-APP staining. Analysis of
the area stained with IgG (in mm2) was performed
using a computer-based image analysis system (Image
J 1.45, Wayne Rasband, National Institutes of Health,
Bethesda, USA). A threshold for positive IgG staining
was chosen by manually evaluating a control (sham)
animal for IgG staining and this threshold was then
kept equal for all included animals. The stained area
was then converted to mm2 using a reference area.Target Supplier
precursor protein Invitrogen Life Technologies Europe, BV, Netherlands
strocytes Santa Cruz Biotechnology, Inc. CA, USA
strocytes Dakocytomation A/S Glostrup, Denmark
icroglia Cederlane, Ontario, Canada
eutrophils Biolegend, San Diego, USA
T-Cells AbSerotec, Dusseldorf, Germany
in barrier leakage Vector laboratories, Burlingame, CA, USA
dary antibody Vector laboratories
dary antibody Vector laboratories
dary antibody Vector laboratories
dary antibody Vector laboratories
Figure 2 (See legend on next page.)
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Figure 2 Schematic overview of the vimentin and GFAP staining after central fluid percussion injury (cFPI) in mice at post-injury day
1,3 and 7. (A) The immunoreactivity for vimentin was increased in the cortex, the subcortical white matter, the fimbria of hippocampus and the
dentate gyrus of hippocampus in addition to the external and internal capsule (arrow), especially at 3 days post-injury. Note the absence of
increased vimentin staining in the thalamus; (B) Sham-injured animals showed some background staining of GFAP, which increased after cFPI.
The increased GFAP staining was observed in the cortex, the subcortical white matter, the fimbria of hippocampus and the dentate gyrus of the
hippocampus and in the thalamus (arrow). Note the absence of increased GFAP staining in the internal capsule; (C) Vimentin and GFAP staining
in three different brain regions after cFPI or sham injury; (D) The corpus callosum; (E) the dentate gyrus of the hippocampus and (F) the internal
capsule. PID: Post-injury day.
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To study potential differences in behavioral patterns be-
tween cFPI mice and sham-injured mice, we used the
multivariate concentric square field (MCSF) test using the
same variables as previously described in detail [28]. The
MCSF provides several areas for the animal to explore by
free choice and includes sheltered, open and elevated areas,
a hole-board device and areas with dif-ferent lighting. The
entire arena was divided into zones (Figure 3) that formed
the basis of the description and the variables of the animal’s
performance in the test. Each mouse subjected to cFPI or
sham injury was tested alone in the MCSF at post-injury
day 2 (trial 1) and 9 (trial 2). The testing session lasted for
20 min and the arena was cleaned between each test. Be-
haviors measured in the MCSF were frequencies (FRQ) to
the different zones, duration (DUR, sec) in different zones,
latencies (LAT, sec) to first visit in different zones and for
some variables duration/visit in zones. The variable “total
activity” is the sum of all visits to the different zones, “totalFigure 3 The Multivariate Concentric Square Field (MCSF) arena
and the defined zones. CORR A, B and C, indicate corridors A-C;
DCR is the dark corner room; and SLOPE ENTR is the slope entrance.
START indicates where the animal is placed when introduced to the
arena. Picture modified from [28].corridor”is the sum of corridors A-C, distance moved (cm)
in the whole arena. Velocity (cm/sec) was also measured.
Behavioral recordings
The animals were monitored by a TV-video set-up
(Panasonic Super Dynamic Wv- BP550/B camera and
Panasonic NV-HD640 VHS recorder; Panasonic,
Stockholm, Sweden). The manual scoring of visits to
different zones, FRQ, LAT, DUR and recording of rearing
and grooming was performed using the software Score
version 2.0 (Pär Nyström, Copyright Solids, Uppsala,
Sweden). The Ethovision software version 2.3 (Noldus
Information Technology, Wageningen, Netherlands) was
used for recordings of velocity (cm/sec) and distance
moved (cm) in the MCSF arena.
Statistical analysis
Cell counts and behavioral data were found not to meet
the assumption of normal distribution using the Shapiro-
Wilk’s W-test. Thus, Kruskal-Wallis ANOVA was used and
was followed by Mann–Whitney U-test for pair-wise com-
parisons. After positive test for normal distribution, areas
stained for IgG where analyzed with one-way ANOVA and
Tukey post-hoc test. Parametric data is presented as means
± standard deviations. A P value <0.05 was considered sta-
tistically significant. All analyses were performed using
Statistica 10.0 software (StatSoft Inc., Tulsa, OK, USA).
For the behavioral analysis, principal component analysis
(PCA, [32]) was used as a complement to traditional statis-
tics, to create a score plot showing a summary of the rela-
tionship among the individuals and a loading plot in which
variables important to these relationships can be identified.
The two plots are complementary and superimposable.
This statistical method is very useful for analysis of mater-
ial with large numbers of variables in few numbers of
animals [33,34]. SIMCA-P + 12 software version 12.0
(Umetrics AB, Umeå, Sweden) was used for this purpose.
Results
The cFPI device created a pressure pulse of 1.50 ± 0.24
atm transmitted into the closed cranial cavity of the
animal. In all brain-injured mice, the injury resulted in a
35 ± 18 s (range 17 to 59 s) long apnea. A short-lasting
seizure, typically <5 s, immediately after the impact was
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but two animals. The acute mortality rate was 17.5%
caused by long-lasting apnea (>60 s).General morphology and blood–brain barrier leakage
On macroscopic inspection, no sham-injured mice showed
traumatic subarachnoid blood on the brain surface. At one
day after sham injury, one third of animals had a few,
minor superficial cortical hemorrhages. In contrast, cFPI
mice typically had traumatic subarachnoid blood on the
brain surface at 1 and 3 days post-injury and superficial
cortical hemorrhages were also observed in the parietal
cortex in the majority of animals at these time points (data
not shown).
On H&E-stained coronal sections, two sham-injured
mice showed minimal, superficial damage to the cortical
surface, although a deep lesion and/or a cortical cavity
were not observed. In brain-injured animals, small hemor-
rhages were present in the cortical region underlying the
impact and in the subcortical white matter (Figure 4A).
The cortical injury did not extend into the deeper layers of
the cortex and did not result in a large cortical cavity. At
seven days post-injury, only a few hemorrhages remained
in the cortex. TUNEL staining was undertaken to study
cell death at one day post-injury. There were frequent cells
undergoing apoptotic cell death in the cortex underlying
the impact (Figure 4B,C) but only a few TUNEL-positive
cells were observed in the subcortical white matter and in
the hippocampus (Figure 4C). In 3/5 cFPI animals, there
was intraventricularhemorrhage at one day post-injury
(data not shown).Figure 4 Post-injury hemorrhages and apoptosis. (A) Overview of the i
cFPI, a model of TAI in mice. The injury produces small hemorrhages in the
distribution at one day post-injury; (C) Immunohistochemical image shows
although not in sham-injured controls. PID: Post-injury day.In sham-injured animals, some IgG staining was ap-
parent in the cortex. Although the staining intensity was
highest at three days post-injury, there were no significant
differences between the post-injury days. The staining of
mouse IgG in the brain regions, including the neocortical
and hippocampal areas, underlying the impact had in-
creased 5.7 ± 1.9 fold (560%) at one day post-injury,
indicating increased BBB permeability in these regions
(P<0.05 compared to sham-injured controls; Figure 5A,B).
Although a 2.0 ±1.2 fold (200%) increase in BBB perme-
ability compared to sham-injured controls was observed
up to 7 days post-injury, the staining became progres-
sively weaker with time (P<0.01 between 1 and 7 days
post-injury).
cFPI produces axonal injury identified by β-APP
immunoreactivity
In sham-injured animals, weak β-APP immunoreactivity
was observed in the cortex and brain stem (Figure 6C left)
within nerve cell bodies whereas dendrites, axons and
astroglial processes were unstained.
One day after cFPI, immunoreactive β-APP-positive
axonal profiles appeared in subcortical white matter
(Figure 6B). A few β-APP-positive axonal profiles were also
observed in the dorsolateral rostral brain stem at 1 day
post-injury (Figure 6C), although not at later post-injury
time points. A few β-APP-positive axons were also ob-
served in the dentate gyrus of the hippocampus. The β-
APP immunoreactivity peaked at 1 day, declined at 3 days
and at 7 days post-injury only a few β-APP immunoreac-
tive cells remained in the superficial cortex underlying the
impact site (Figure 6A).njured brain at bregma level −1.5 mm (see Figure 1C) at one day after
cortex underlying the impact; (B) Overview of the TUNEL staining
apoptotic cells in the cortex and dentate gyrus of the hippocampus
Figure 6 Axonal injury after cFPI in mice shown by β-APP immunostaining. (A) Schematic distribution of the β-APP staining in the various
brain regions at 1, 3 and 7 days post-injury; (B) Axonal profiles stained with β-APP in the corpus callosum at 1 day post-injury (for example see
arrow); (C) β-APP positive axonal profiles in the brain stem at 1 day post-injury (right; for example see arrow), compared to a sham-injured animal
with normal staining of nerve cell bodies (left). PID: Post-injury day.
Figure 5 Blood-brain barrier leakage evaluated by mouse IgG staining. (A) Representative images of blood–brain barrier leakage of sham-
and brain-injured animals, identified by IgG staining in the brain regions underlying the craniotomy and impact site; (B) Quantitation of the area
(mm2) stained with IgG (above the pre-set intensity level) at 1, 3 and 7 days after sham injury or central fluid percussion injury (cFPI), presented as
means ± SD. The IgG staining was more intense in sham-injured controls at 3 days compared the 1 and 7 days post-injury time points, although
without reaching statistical significance. *P<0.05; **P<0.01; ***P<0.001 compared to sham-injured controls. PID: Post-injury day.
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Figure 7 Overview of the distribution of microglial, neutrophil and T-cell staining at 1, 3 and 7 days after cFPI or sham-injury in mice.
(A-C) The microglial staining was increased throughout the observation period in the cortex and in the subcortical white matter, especially at one
day post-injury. Infiltrating neutrophils appeared at one day post-injury in the cortex and subcortical white matter. T-cells were observed in the
cortex and in the subcortical white matter after one day post-injury but then the number of cells declined; (D) The inflammatory response after
cFPI or sham-injury. The images show activated microglia/macrophages (MAC-2), neutrophils (GR-1) and T-cells (CD3) in the external capsule from
post-injury day (PID) 1 to 7, examples of cells staining positive for the cell type marker are indicated with arrows. Inserts show the same area in
the external capsule at a higher magnification; (E) Cell counts of microglia/macrophages, neutrophils and T-cells in the corpus callosum, external
capsule and fimbria of hippocampus from 1, 3 and 7 days post-injury (presented as means ± SD). *Indicates a statistically significant difference
compared to sham-injured controls (P<0.05).
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after cFPI
In order to determine the astroglial response after cFPI,
analysis of vimentin and GFAP immunostaining was
performed. The brains of sham-injured control animals
displayed vimentin immunoreactivity only in ependymal
cells and to a minimal extent in the neocortex (Figure 2A).
One day after cFPI, there were star-shaped vimentin
positive cells in the subcortical white matter and a few cells
appeared in the hippocampal CA2 region (Figure 2A). At 3
days post-injury there were numerous immunoreactive
cells widespread in the cortex, in the subcortical white
matter including the corpus callosum and external capsule,
and in the hippocampus (Figure 2). There were also
vimentin-positive cells lining the lateral ventricles (different
from the ependymal cells observed in sham-injured con-
trols) and in the internal capsule although not in the thal-
amus (Figure 2A). Although the expression of vimentin
persisted in the thalamus at 7 days post-injury, there were
markedly fewer cells immunoreactive for vimentin in the
hippocampus. In the cortex, there were fewer vimentin-
positive cells in contrast to the internal capsule, showing
more vimentin-positive cells at this time-point (Figure 2A).
Immunostaining of GFAP was observed in sham-
injured controls in the white matter, in the hippocampus
and to some extent in the neocortex and in the epen-
dymal cells (for an overview see Figure 2B). There was a
slightly increased GFAP staining intensity in the cortex
and the subcortical white matter in 2/3 of the sham-
injured animals after 1 and 3 days post-injury at bregma
levels 0 and −1.5 mm compared to other brain regions.
At 1 day post-injury, the GFAP immunoreactivity was
increased in the cortex, in the hippocampus and to some
extent in the external capsule compared to sham-injured
controls. By 3 days post-injury, there were numerous
star-shaped GFAP-positive astrocytes throughout the
neocortex, in the hippocampus and external capsule
(Figure 2B,E). The GFAP immunoreactivity was not
increased in the internal capsule (Figure 2B,F). A few
GFAP-positive cells also appeared in the thalamus. At 7
days post-injury, the number of GFAP-positive astro-
cytes in the thalamus had increased. Overall, the immu-
noreactivity of GFAP in the hippocampus was weaker
compared to 3 days post-injury (Figure 2B).The neuroinflammatory response
To establish the time-course of immune cell infiltration
into the cortex and white matter in the cFPI model, the
number of three different immune cell types was esti-
mated in the corpus callosum, the external capsule and
the fimbriae (Figure 7A-C).
Sham-injured controls showed very few or no cells that
were immunoreactive for Mac-2 (activated microglia/mac-
rophages), GR-1 (neutrophils) or CD3 (T-cells; Figure 7A-E).
One day post-injury, numerous activated microglia/
macrophages were shown in the cortex, in white matter
tracts including the corpus callosum, the external capsule
and the fimbriae, and in the hippocampus (Figure 7A,D).
The number of Mac-2 positive cells was elevated compared
to sham-injured controls (P<0.05) without significant
changes from 1 to 7 days post-injury (Figure 7E). These
cells were observed in healthy-appearing tissue, i.e., with-
out signs of cell death or necrosis. Neutrophils, stained
with GR-1, were observed in the same regions as the
microglia/macrophages although the number of cells was
lower. The number of cells was unchanged over time with
only a minimal decrease at 3 days post-injury (Figure 7B,E).
The number of CD3-positive T-cells peaked at 1 day
post-injury and then declined (Figure 7C-E). Infiltrating
neutrophils and T-cells were predominately visualized
in injured cortical and subcortical regions underlying
the impact (Figure 7C).
Functional outcome evaluation
In both trial 1 and trial 2 of the MCSF test, some significant
differences between sham-injured controls and cFPI ani-
mals were observed (Table 2). In general, in the first trial,
cFPI mice crossed the centre of the arena less frequently
(FRQ CENTRE, P<0.05) and made shorter visits to the hur-
dle (DUR/FRQ HURDLE, P <0.05) compared to sham-
injured controls. There were no significant differences in
distance moved between cFPI mice (5,185 ± 1,074 cm) or
sham-injured mice (4907 ± 933 cm). In the second trial,
cFPI mice crossed the centre less frequently (FRQ
CENTRE, P<0.05), had fewer visits to the corridors
(TOTAL CORRIDORS, P<0.05) and were less active in the
whole arena (TOTAL ACTIVITY, P<0.05) compared to
sham-injured controls. Brain-injured mice spent more time
in the centre of the arena (a non-significant trend) and less
Table 2 MCSF results following sham injury and cFPI brain injury
PARAMETERS Sham Trial 1 cFPI Trial 1 Sham Trial 2 cFPI Trial 2
LATENCY (sec)
LEAVE CENTRE 78.3 ± 50.5 150 ± 285.8 5.2 ± 3.9 12 ± 13.5
DCR 217.9 ± 188 301.1 ± 299.5 109 ± 19.9 73.3 ± 67.5
SLOPE ENTRANCE 164.4 ± 111.5 261.3 ± 287.6 89.5 ± 98.8 76.5 ± 131.4
SLOPE 525.8 ± 425.2 650 ± 390.7 577.9 ± 495.4 627.1 ± 509.2
BRIGDE 639.9 ± 497.6 768.6 ± 421.8 682.1 ± 485.8 689.3 ± 516
HURDLE 179.2 ± 154 267.4 ± 292 58.4 ± 64.5 106.4 ± 98.9
CENTRAL CIRCLE 31 ± 45.5 55.7 ± 53.7 130.1 ± 109.3 87.9 ± 86.9
REARING 59.7 ± 40.4 49.9 ± 35.7 65.8 ± 70.8 34.8 ± 45.3
GROOMING 363.2 ± 347.3 280.7 ± 360.2 570.7 ± 413.9 547.7 ± 495.9
FREQUENCY
CENTRE 24.1 ± 5.7 17.4 ± 7 * 36.6 ± 6.4 29.4 ± 9.4*
DCR 10.5 ± 4.4 8.1 ± 4.4 16.1 ± 6.2 16.5 ± 5.8
SLOPE ENTRANCE 8.4 ± 2.0 7.3 ± 3.5 10.5 ± 2.1 10.1 ± 3.6
SLOPE 2.7 ± 1.8 2.1 ± 2 3.5 ± 3.1 2.3 ± 2.3
BRIDGE 3.7 ± 3.5 3.1 ± 3.4 2.7 ± 2.6 2.8 ± 2.8
HURDLE 10 ± 2.9 11.7 ± 5.2 13.1 ± 3 11.1 ± 4.3
CENTRAL CIRCLE 10.5 ± 4.4 13.8 ± 7 8.9 ± 4.2 8.9 ± 4.6
TOTAL CORRIDORS 33.3 ± 6.9 28.1 ± 10.1 58.8 ± 6.4 51.1 ± 12.7 *
REARING 63 ± 23 81.8 ± 20.7 62.5 ± 24 60.1 ± 28.5
GROOMING 1.9 ± 1.1 2.7 ± 1.5 1.2 ± 0.8 0.9 ± 0.9
DURATION (sec)
CENTRE 226.3 ± 53.3 345.2 ± 234 127.7 ± 21.5 139.2±13
DCR 166.6 ± 72.2 149.2 ± 99.2 235.9 ± 90 334.2 ± 160.1
SLOPE ENTRANCE 51.7 ± 10 44.8 ± 23.6 59.5 ± 21.7 57.1 ± 25.7
SLOPE 70.7 ± 50 57.8 ± 57.9 45.3 ± 41.6 50.3 ± 47.7
BRIGDE 56.8 ± 55.7 47.7 ± 47.1 39.6 ± 45.2 42.2 ± 47.5
HURDLE 175.2 ± 61.1 154.6 ± 67.3 178.8 ± 53.8 138.1 ± 59.2
CENTRAL CIRCLE 13.2 ± 20.7 13.9 ± 21.5 4.4 ± 2.6 4.4 ± 2.3
TOTAL CORRIDORS 401.5 ± 68 359.7 ± 120.1 464.3 ± 98.8 399.9 ± 91.7
GROOMING 12.6 ± 9.2 29.5 ± 30.8 9.3 ± 9.9 5.8 ± 7.2
DURATION/FREQUENCY
DCR 16 ± 4.3 17.4 ± 8 15 ± 3.7 20.7 ± 8.5
SLOPE ENTRANCE 6.4 ± 1.7 6.3 ± 3.4 5.7 ± 1.7 5.5 ± 2
SLOPE 20.5 ± 15 23.7 ± 22.3 9.1 ± 8.1 22.6 ± 38.4
BRIDGE 9.4 ± 8.7 11.8 ± 11.1 8.4 ± 7.9 8.8 ± 8.7
HURDLE 17.7 ± 4.8 12.6 ± 4.4 * 13.9 ± 3.6 12.7 ± 3.8
TOTAL CORRIDORS 12.7 ± 3.4 12.6 ± 5.1 8.1 ± 2.4 8.1 ± 2.3
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Table 2 MCSF results following sham injury and cFPI brain injury (Continued)
ACTIVITY MEASURES
TOTAL ACTIVITY 105 ± 19.8 95 ± 25.6 157.7 ± 19.3 137.2 ± 31.9 *
DISTANCE MOVED (cm) 4907 ± 933 5185 ± 1074.5 4865 ± 745.7 4644 ± 1204
VELOCITY ARENA (cm/s) 5 ± 0.7 5.5 ± 0.8 5.1 ± 0.7 4.7 ± 1.1
VELOCITY CENTRAL CIRCLE (cm/s) 14.8 ± 4.1 15.6 ± 5.4 22.8 ± 3.7 20.5 ± 8.9
HEAD DIPS 16.5 ± 7.7 9.8 ± 7.4 13 ± 4.6 13.1 ± 8.1
Behavioral parameters of sham-injured and cFPI brain-injured mice in the multivariate concentric square field test during the first and second trial at post-injury
day 2 and 9, respectively. Values represent mean ± standard deviation. Sham n = 10, cFPI n = 16. *P<0.05 compared to sham-injured mice analyzed by Kruskal-
Wallis test and Mann–Whitney U test.
cFPI: Central fluid percussion injury; DCR: Dark corner room.
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direct observation in the MCSF test, it was clear that cFPI
mice were running around in circles in the centre of the
arena, indicating a pathological behavior.
Historical data obtained from a previously published
report using the MCSF in mice subjected to the con-
trolled cortical impact TBI model [CCI; 28] allowed us
to compare the behavioral deficits caused by diffuse
(cFPI) and focal (CCI)TBI. The MCSF data from CCI-
injured animals was obtained using the same set-up
performed by the same investigator (S. E-L) as in the
present study and it was apparent that the behavioral
profiles of cFPI mice and CCI-injured mice [28]) were
markedly different (Figures 8 and 9).
Discussion
The aim of the study was to characterize the astroglial re-
actions, neuroinflammatory response and complex behav-
ioral changes following cFPI in mice, a model of diffuse
TAI. In sham-injured controls, there was some BBB leak-
age, a transient vimentin response and a limited number
of infiltrating immune cells, presumably caused by drilling
of the thin skull bone. These findings suggest that sham-
injured animals are different from naïve animals, as previ-
ously shown by us [28,35] and others [26,36]. The cFPI
resulted in an acute apnea and seizures with 18% mortal-
ity. In the injured brains, there was a long-lasting perme-
ability increase of the BBB and cortical hemorrhages likely
caused by impact-induced shear stress. Using TUNEL
staining, frequent apoptotic cells were observed in the cor-
tex underlying the impact although only rarely in the sub-
cortical white matter and hippocampus. Animals showing
prolonged apneas died and we arbitrarily chose a cut-off
apnea length of 60s. Similarly, apnea immediately follow-
ing impact is a feature of cFPI in the rat [37,38]. Since
most animals had a substantially shorter apnea, a mean of
35 s, apnea-induced hypoxia contributing to our present
results is unlikely.
Post-injury development of seizures is a feature of many
experimental TBI models [39-41], although not previously
evaluated in this mouse TAI model. We observed seizures
immediately post-injury by direct visual inspection. In thelateral fluid percussion brain injury and weight drop injury
in rats, there is immediate extracellular electrolyte and
transmitter disturbances leading to cortical spreading de-
pression and seizure activity [41,42]. In the original report
using the cFPI model in mice [5], no TUNEL-positive
cells, apnea or seizures were reported despite similar at-
mospheric pressure to the present report (1.7 vs. 1.5 atm,
respectively). When using the FPI models, atmospheric
pressure does not fully define injury severity in compari-
son between laboratories [29]. It is plausible that the apnea
and seizures in our report reflect a more marked brain dis-
placement also involving the brain stem and indicate a
more severe injury level compared to the report by Greer
et al. [5]. Additionally, the degree of cortical damage is as-
sociated with seizure susceptibility [43] and post-traumatic
epilepsy is common in the lateral FPI model in mice
[39]. Following cFPI in the rat, no enhanced seizure sus-
ceptibility to pentylenetetrazol (PTZ) was found [38],
despite an increased neuronal excitability [44]. Although
the detailed electrophysiological response to cFPI has
not been established, immediate seizures have been ob-
served in other diffuse head injury models [45] and it
was thus not surprising to observe post-injury seizures
also in the mouse cFPI model. Even though it may be ar-
gued that transient acute apnea and seizures add to the
complexity of the cFPI model, these phenomena are im-
portant in a clinically-relevant model since they are
commonly observed in TBI victims.
Axonal injury after cFPI
Increased β-APP immunoreactivity was observed in the
cortex, subcortical white matter, external capsule and the
hippocampus of injured animals indicating that the cFPI
model mimics human DAI. The immunoreactivity for β-
APP in white matter tracts was transient and could not be
observed beyond 3 days post-injury. Importantly, injured
brainstem axons may play a major role in the induction of
post-traumatic coma [46] and were also observed in the
cFPI model. The β-APP staining was consistent with the
spatial distribution of β-APP swellings previously observed
in the rat model of mild cFPI [25,47-49]. In the first publi-




















Trial 1 CCI and cFPI (PCA-X)




























































Trial 1 CCI and cFPI (PCA-X)






































SIMCA-P+ 12.0.1 - 2012-06-05 12:02:26 (UTC+1) 
Figure 8 (See legend on next page.)
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Figure 8 The principal component analysis (PCA) from the first MCSF test at 2 days post-injury. To test the hypothesis that the mouse
cFPI model induces unique behavioral deficits compared to a focal traumatic brain injury (TBI) model, we extracted historical data [28] obtained
under an identical set-up and by the same investigator. (A) PCA score plot showing a comparison between mice subjected to the controlled
cortical impact (CCI, producing a focal TBI) model and the cFPI model, producing wide-spread traumatic axonal injury. The behavioral patterns of
the two TBI models are markedly different; (B) PCA loading plot illustrating the MCSF variables that were included in the analysis. Variables
located further away from the origin are most important for the model. CCI: Controlled cortical impact, n = 11 (from [28]); cFPI: Central fluid
percussion injury, n= 15; CTRCI: Central circle; Dur: Duration; D/V: Duration per visit; Frq: Frequency; Lat: Latency; SLOPE E: Slope entrance; TOT
ACTIVITY: Total activity in arena; TOTCORR: Total corridor entries.
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white matter already at 15 min post-injury. However, APP
immunoreactivity was not observed beyond two days
post-injury in the previous study [5], compared to three
days in the present study. The mechanisms for the transient
appearance of β-APP are unknown but may be due to accu-
mulation of β-APP degrading enzymes within injured axons
[50-52]. Increased β-APP immunostaining in white matter
tracts is a consistent feature of experimental TBI models
including the Marmarou impact acceleration and lateral
fluid percussion injury (lFPI) models in rats [53-55].
Following TAI, secondary axotomy and subsequent
Wallerian degeneration lead to downstream synaptic
degeneration and deafferentation of postsynaptic targets
[48,56]. However, perisomatic thalamic axotomy after
cFPI in rats is associated with neuronal atrophy rather
than cell death [49] and reactive sprouting accompanied
by axonal elongation over time was observed following
cFPI in mice [5]. These results suggest that endogenous
restorative efforts are elicited post-injury and that treat-
ments targeting axonal injury should be addressed in
experimental TBI research.
Marked astroglial cell reactivity after cFPI
Activation of astrocytes and reactive gliosis are key fea-
tures observed in many CNS diseases including neu-
rotrauma [57,58]. Reactive astrocytes play important
roles in wound healing and neuronal regeneration and
constitute the main cellular component of the glial scar
[59]. Increased GFAP immunoreactivity is considered to
be one sensitive marker of glial activation [60] and
vimentin another early sign of astrocyte activation in
CNS injury [61,62]. Following TBI, hypertrophic and
proliferating astrocytes have been attributed to both
beneficial and detrimental consequences. When reactive
astrocytes were ablated following CCI in mice, there was
an increased loss of cortical tissue suggesting that react-
ive astrocytes play an important role in preserving
neural tissue and in restricting inflammation [63].
In our present study, vimentin immunoreactive cells were
numerous in the cortex, in the subcortical white matter, in
the hippocampus and in the internal capsule, while groups
of GFAP positive cells were also observed in the thalamus.
Both vimentin and GFAP immunoreactivity was slightlydecreased at 7 days post-injury. In contrast to vimentin, the
GFAP immunoreactivity was not increased in the internal
capsule. These results indicate a different astroglial re-
sponse between astrocytes expressing vimentin or GFAP
[64,65]. Previously, a prolonged, widespread astrocytic re-
sponse was observed in the subcortical white matter after
CCI brain injury in mice and rats [66]. Vasogeni cedema,
indicated by plasma protein leakage, was increased up to 7
days post-injury in the present study. The brain regions
showing increased BBB permeability correlated with in-
creased immunoreactivity for vimentin/GFAP and β-APP
staining, similar to findings observed following CCI in the
rat [62]. The exact function of vimentin in the adult brain
following TBI is not known, although GFAP and vimentin
may have overlapping functions since only mice with a gene
deletion of both GFAP and vimentin exhibit attenuated
glial scar reactions after neurotrauma [67].
These two astrocyte markers were thus up-regulated
with, to some extent, different distribution and time course
post-injury, in line with our previous findings of a wider
distribution and longer time course of vimentin compared
to GFAP following severe CCI mouse [62]. The combined
results suggest variable astroglial activation depending on
brain region and astrocyte subtype post-TBI. There is evi-
dence that GFAP and vimentin expression is differentially
regulated [61], and it is plausible that the delayed and more
wide-spread vimentin expression observed in our present
report is related to specific regional cytokine responses
which should be addressed in future studies.
The inflammatory response in white matter tracts after cFPI
Recently, it has become apparent that the central nervous
system is not immunologically privileged. TBI induces an
immune response, which includes both activation of
microglia and infiltration of leukocytes and T-cells into in-
jured brain tissue [68]. Our previous studies in a mouse
CCI model showed a robust, early up-regulation of a num-
ber of inflammatory genes, including chemokines and
their receptors, and a marked cellular inflammatory re-
sponse consisting of infiltrating neutrophils and T-cells
and activation of microglia [69-72]. Suppression of acute
cytokine and chemokine up-regulation by anti-inflam-
matory agents has improved outcome in experimental TBI
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Figure 9 The principal component analysis (PCA) from the second MCSF test, 7 (CCI-injured animals, [28]) or 9 (cFPI animals) days
post-injury. (A) PCA score plot showing the locations of the CCI and cFPI groups, indicating different behavioral patterns in the two groups; (B)
PCA loading plot illustrating the MCSF variables that are included in the analysis. Variables located further away from the origin are most
important for the model. CCI: Controlled cortical impact, n = 11 (from [28]); cFPI: Central fluid percussion injury, n = 16; CTRCI: Central circle; Dur:
Duration; D/V: Duration per visit; Frq: Frequency; Lat: Latency; SLOPE E: Slope entrance; TOT ACTIVITY: Total activity in arena; TOTCORR: Total
corridor entries.
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plex interplay with the systemic immune system [76,77].
Importantly, recent data from DAI patients obtained using
cerebral microdialysis demonstrate a complex temporal
pattern of inflammatory biomarkers (e.g., cytokines,
chemokines), implying that inflammation may be an im-
portant mechanism in axonal injury [76]. In a previous
study in CCI mice both microglia and invading mono-
cytes/macrophages were identified by flow cytometry as a
part of the post-traumatic inflammatory response [70]. In
our present study, activated microglia/macrophages stained
with MAC-2 remained high in the subcortical white matter
from one to seven days post-injury. This antibody does not
distinguish between macrophages and microglial cell types
and morphology alone may not be sufficient to differentiate
between these two cell types. An extended study using
additional antibody markers following TBI could provide
information on the distinction between resident microglia
and blood-stream derived macrophages.
We also observed a limited number of neutrophils in-
filtrating the white matter tracts, peaking at 1 day after
cFPI. Similarly, the infiltration of CD3+ T-cells in the
white matter tracts peaked at day 1 post-injury and de-
clined at the later time points. In summary, there was a
robust inflammatory response after cFPI in mice, espe-
cially at 1 day post-injury. Microglia is one cell type that
synthesizes and releases interleukin-1β (IL-1β), a pro-
inflammatory cytokine protein which is an important
mediator of the inflammatory response [78-81]. In a pre-
vious report, microglial activation was observed after
cFPI in the rat as early as 6 hours post-injury and there
was a spatiotemporal relationship with TAI [25]. Rapid
recruitment of neutrophils is part of the early inflamma-
tory response following human TBI [82]. Neutrophils
may trigger increased vascular permeability [83,84] and
release of reactive oxygen species, proteases and pro-
inflammatory cytokines [85]. Further, neutrophil depletion
at the time of TBI was neuroprotective [86]. Although
T-lymphocytes have been shown to infiltrate the brain
parenchyma in focal TBI models in the rat [71,87], only
a minimal cortical infiltration of T-cell receptor (TcR)-
positive cells was observed at seven days following CCI
in the mouse [80]. Here, we used the marker CD3, re-
quired for T-cell activation, of which antigen is bound
to the membrane of all mature T-cells. The CD3 immu-
noreactivity peaked at 1 day post-injury, and thenumber of T-cells in the white matter tract was signifi-
cantly increased. However, further analysis is needed to
distinguish between different T-lymphocyte subtypes in
this TBI model.
Complex behavioral changes are elicited by cFPI
Functional outcome analysis is crucial in TBI research and
we hypothesized that cFPI model could induce behavioral
disturbances. In the first trial in the MCSF, all animals
were facing a novel environment and they freely started to
explore the arena using various explorative strategies
[28,88,89]. Compared to sham-injured animals, the behav-
ioral pattern of cFPI animals were different. In both trials,
cFPI mice were passing the centre of the arena fewer
times, hence changing zones in the arena, compared to
sham-injured controls. Furthermore, the cFPI mice had
less activity in the whole arena, made fewer visits to corri-
dors and spent more time running around in circles in the
centre of the arena indicating a pathological behavior.
Although the cFPI model and other models of TAI in
the rat induce cognitive impairment [90], there are no pre-
vious reports evaluating complex behavioral disturbances
in rodent TAI models. To test the hypothesis that the
behavioral disturbances induced by cFPI were unique, we
extracted previously published behavioral MCSF data [28]
from mice subjected to the focal CCI model. From the
PCA, it was apparent that mice subjected to a focal TBI
(CCI) or cFPI used different behavioral strategies and
displayed altered behavioral patterns (Figures 8 and 9). In
the first trial, cFPI-animals spent more time in the centre
of the arena and made more rears. In the second trial,
cFPI mice remained more active, spent more time in the
central circle, made more visits to the centre of the arena
and made more rears compared to the CCI-injured mice
[28]. Although direct comparisons between the previously
published [28] and present data must be made with cau-
tion, an identical experimental set-up was used and all be-
havioral testing was performed by the same investigator.
These results argue that the cFPI model induces unique
behavioral deficits with a markedly different pattern com-
pared to focal TBI.
In our report, the first to study behavioral outcome in
the cFPI model in mice, it was obvious that the cFPI
model induced a unique pathological behavior pattern dif-
ferent from that observed in sham-injured controls and in
mice subjected to focal TBI [28]. Our results support the
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plex behavioral disturbances post-TBI. In the development
of novel TAI treatment options, behavioral outcome stud-
ies are crucial and the MCSF appears to be a suitable test
for addressing complex behavioral changes induced by
axonal injury.
Conclusions
The cFPI model in mice resulted in increased blood–brain
barrier permeability, diffuse axonal injury, widespread
astroglial cell reactivity and a robust inflammatory re-
sponse including activation of microglia/macrophages, in-
filtration of neutrophils and T-cells. The distribution of
axonal damage was less widespread than the immunoreac-
tivity of glial cells positive for vimentin and GFAP. The in-
flammatory response was restricted to the cortex and the
subcortical white matter and included areas of axonal in-
jury. Additionally, there were complex behavioral changes
observed in brain-injured animals that appeared unique to
this TBI model. Our results argue that behavioral evalu-
ation is crucial in the evaluation of traumatic axonal in-
jury. The widespread axonal injury observed in this
model reflects many of the clinical features observed in
TBI patients. Further analysis including evaluation at
later time-points is needed to study the long-term conse-
quences initiated by the cFPI. It is likely that the mouse
central fluid percussion injury model can be an important
complement to other TBI models for the study of patho-
logical mechanisms including neuroinflammation and treat-
ment strategies for diffuse traumatic axonal injury.
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